Mathew Blackman

Stock Analyst at TD Cowen

(4.12)
# 1,674
Out of 4,994 analysts
276
Total ratings
47.1%
Success rate
9.1%
Average return

Stocks Rated by Mathew Blackman

Stryker
Sep 22, 2026
Rated: Hold
Price Target: $355$298
Current: $275.09
Upside: +8.33%
Beta Bionics
Sep 14, 2026
Reiterated: Hold
Price Target: $16$18
Current: $22.81
Upside: -21.09%
Globus Medical
Aug 6, 2026
Reiterated: Buy
Price Target: $115
Current: $75.19
Upside: +52.95%
Insulet
Aug 6, 2026
Rated: Hold
Price Target: $294$144
Current: $139.38
Upside: +3.31%
Tandem Diabetes Care
Aug 6, 2026
Reiterated: Buy
Price Target: $28
Current: $17.50
Upside: +60.00%
Alphatec Holdings
Aug 5, 2026
Rated: Buy
Price Target: $11$13
Current: $10.33
Upside: +25.85%
Orthofix Medical
Aug 5, 2026
Reiterated: Hold
Price Target: $12
Current: $8.98
Upside: +33.63%
Zimmer Biomet Holdings
Aug 5, 2026
Reiterated: Buy
Price Target: $109$115
Current: $93.98
Upside: +22.37%
OrthoPediatrics
Aug 4, 2026
Reiterated: Buy
Price Target: $23
Current: $22.76
Upside: +1.05%
SI-BONE
Aug 4, 2026
Rated: Buy
Price Target: $18$20
Current: $18.81
Upside: +6.33%
Reiterated: Buy
Price Target: $485
Current: $402.09
Upside: +20.62%
Reiterated: Buy
Price Target: $25
Current: $15.79
Upside: n/a
Reiterated: Hold
Price Target: $10$7
Current: $5.23
Upside: n/a
Reiterated: Buy
Price Target: $100
Current: $89.53
Upside: n/a
Reiterated: Buy
Price Target: $301$318
Current: $319.39
Upside: n/a
Reiterated: Buy
Price Target: $50
Current: $10.06
Upside: n/a
Reiterated: Hold
Price Target: $10$11
Current: $5.77
Upside: n/a
Reiterated: Buy
Price Target: $3
Current: $2.67
Upside: n/a